Drug companies' patent-extending strategies substantially increase health care costs
Evergreening strategies—where pharmaceutical companies slightly change the formulation of their brand drug into "follow on" drugs by combining formulations or producing slow-release forms, for example, so that they can ...
Jun 4, 2013
0
0